NCT02071888 2018-07-18Study of the Glutaminase Inhibitor CB-839 in Hematological TumorsCalithera Biosciences, IncPhase 1 Completed25 enrolled
NCT01110135 2017-05-24Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple MyelomaUniversity of WashingtonPhase 2 Completed43 enrolled 5 charts
NCT00150462 2017-05-02Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological MalignanciesAmgenPhase 1 Completed48 enrolled 26 charts